in , ,

Sputnik V vaccines protects from all known Covid variants: Gamaleya Institute Head

Sputnik V vaccine
Im,age source: Twitter

Head of Gamaleya Research Institute of Epidemiology and Microbiology, Alexander Gintsburg on Tuesday stated that the Russian-made Sputnik V vaccine protects against all known variants of Covid-19.
Gamaleya Research Institute of Epidemiology and Microbiology is the institute where Sputnik V was developed.

Sputnik V is the third vaccine after Covishield and Covaxin to have received emergency use approval in India. The two-dose adenoviral vector-based coronavirus vaccine is being administered in select private hospitals for Rs Rs 1,145 per dose.
In a statement on Tuesday, Alexander Gintsburg stated –
“Antibodies developed after vaccination with #SputnikV protects from all variants of COVID known today, starting from the UK variant to the so-called Delta variant, first detected in India.”

Taking to Twitter, official page of Sputnik V informed –
“”Antibodies developed after vaccination with #SputnikV protect from all variants of COVID known today, starting from the UK variant to the so-called Delta variant, first detected in India” – Head of the Gamaleya Center academician Alexander Gintsburg.”

The UK strain (B.1.1.7), tagged by the World Health Organisation (WHO) as the Alpha variant, was first discovered in Kent in September of last year. The strain, which has 23 known mutations so far, has become the dominant variant both in the UK and the United States.
On the other hand, the Delta (B.1.617.2) variant was first found in India in October of last year. The highly transmissible strain has been identified as one of the drivers of the second wave of Covid-19 infections that devastated parts of the country in May. The highly transmissible Delta variant has further mutated to form the Delta Plus variant.

The Russian Direct Investment Fund (RDIF) cited a study on June 15 to say that Sputnik V is “more efficient against the Delta variant” of coronavirus than any other vaccine that has published results on the strain so far. The Gamaleya Center study has been “submitted for publication in an international peer-reviewed journal”, said a tweet from the Russian-made vaccine’s official Twitter handle.

In fact, the makers of Sputnik V have offered booster shots to other vaccine makers to combat the Delta variant of coronavirus.
Approved for emergency use in 67 countries, Sputnik V has an efficacy rate of over 91.6 percent.

Also Read: Covid 19 Second Wave and Acute Shortage of Oxygen in India

What do you think?

Written by Headline8 Desk


Leave a Reply

Your email address will not be published. Required fields are marked *


CBSE class 12 compartmental exam

SC dismisses plea challenging cancellation of CBSE Class 12 Compartmental examination

Guwahati Police Seized 1.6 Lakh Yaba Tablets